Lobe Sciences Ltd.: Lobe Sciences Announces Roadmap for Remainder of 2022 and Early 2023
Vancouver, British Columbia--(Newsfile Corp. - June 14, 2022) - Lobe Sciences Ltd. (CSE: LOBE) (OTCQB: LOBED) ("Lobe" or the "Company"), a Canadian Biopharmaceutical Company committed to discovering and
Source: finanznachrichten.de